GO:0031960 response to corticosteroid: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0031960 response to corticosteroid describes any process by which a cell or organism changes its state or activity in response to corticosteroid hormones, including glucocorticoids and mineralocorticoids.
• Corticosteroids are adrenal cortex-derived steroid hormones that regulate stress response, immune response, inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior.
• Genetic factors significantly influence interindividual variability in corticosteroid response, as shown in asthma and COPD studies.
• Corticosteroid response is clinically important in immune thrombocytopenic purpura, cryptogenic organizing pneumonia, hard metal lung disease, and psychiatric adverse effects such as mania.
• Key genes involved include NR3C1 (glucocorticoid receptor), NR3C2 (mineralocorticoid receptor), HSD11B1, HSD11B2, FKBP5, and others that modulate ligand availability and receptor signaling.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of genes in the response to corticosteroid pathway.
Description
GO:0031960 response to corticosteroid is a Gene Ontology biological process term that captures the full spectrum of cellular and organismal changes triggered by corticosteroid hormones. Corticosteroids are steroid hormones produced in the adrenal cortex and include glucocorticoids and mineralocorticoids, which collectively regulate stress response, immune response, inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior. This term is essential for researchers because corticosteroid signaling is a central axis in endocrine, immune, and metabolic physiology, and its dysregulation underlies numerous diseases.
response to corticosteroid At A Glance
| GO ID | GO:0031960 |
|---|---|
| GO term | response to corticosteroid |
| Ontology | biological_process |
| Synonym | response to corticosteroid stimulus |
| Major function | Mediates cellular and organismal changes in response to glucocorticoids and mineralocorticoids, affecting stress response, immune response, inflammation, metabolism, electrolyte balance, and behavior |
| Definition source | QuickGO |
| Related hormones | Glucocorticoids (e.g., cortisol) and mineralocorticoids (e.g., aldosterone) |
| Key receptor genes | NR3C1, NR3C2 |
| Clinical relevance | Asthma, COPD, immune thrombocytopenic purpura, cryptogenic organizing pneumonia, psychiatric adverse effects |
What Is GO:0031960?
According to the QuickGO definition, GO:0031960 response to corticosteroid refers to any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosteroid hormone stimulus. A corticosteroid is a steroid hormone produced in the adrenal cortex. Corticosteroids are involved in a wide range of physiologic systems such as stress response, immune response and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior. They include glucocorticoids and mineralocorticoids. The synonym response to corticosteroid stimulus is also used.
Why Is response to corticosteroid Important in Cell Biology?
Understanding GO:0031960 response to corticosteroid is critical because corticosteroids are among the most widely prescribed drugs, and interindividual variability in response is substantial. Genetic factors influence inhaled corticosteroid response in children with asthma, and machine learning models can predict response to inhaled corticosteroid maintenance therapy in COPD. Corticosteroid response also determines outcomes in immune thrombocytopenic purpura, cryptogenic organizing pneumonia, and hard metal lung disease. Moreover, psychiatric adverse effects such as mania are significant concerns. Elucidating the molecular players in this pathway can guide personalized therapy and identify novel drug targets.
• Corticosteroids are first-line therapy for many inflammatory and autoimmune diseases, and response variability affects clinical outcomes.
• Genetic polymorphisms in genes such as NR3C1 and FKBP5 modulate corticosteroid sensitivity and adverse effects.
• Corticosteroid response is central to asthma and COPD management, where inhaled corticosteroids are mainstays.
• In immune thrombocytopenic purpura, biomarkers can predict response to corticosteroid therapy.
• Cryptogenic organizing pneumonia often responds favorably to corticosteroids, but relapses occur.
• Hard metal lung disease can show favorable response to corticosteroid treatment.
• Psychiatric adverse effects, including mania, are associated with corticosteroid use and require monitoring.
• Long-term systemic corticosteroid exposure carries cumulative risks that necessitate understanding of response mechanisms.
• CRISPR-based models enable functional validation of genes in the response to corticosteroid pathway.
• Bioinformatics and machine learning approaches are emerging to predict corticosteroid response.
What Happens During response to corticosteroid?
Hormone Availability and Receptor Binding
In simple terms: Corticosteroid hormones travel through the blood and enter cells, where they bind to specific receptor proteins.
Corticosteroids such as cortisol and aldosterone circulate and diffuse into cells. Intracellular 11beta-hydroxysteroid dehydrogenases (HSD11B1 and HSD11B2) regulate local ligand availability by interconverting active and inactive forms. The glucocorticoid receptor (NR3C1) and mineralocorticoid receptor (NR3C2) bind corticosteroids with high affinity, triggering conformational changes that release heat shock proteins and expose nuclear localization signals.
Receptor Activation and Nuclear Translocation
In simple terms: Once bound, the receptor moves into the nucleus to control gene expression.
Ligand-bound NR3C1 and NR3C2 translocate to the nucleus, where they bind glucocorticoid response elements (GREs) or negative GREs in target genes. This modulates transcription of genes involved in inflammation, metabolism, and stress response. Coactivators and corepressors such as FKBP5 further fine-tune receptor activity.
Transcriptional and Non-Transcriptional Effects
In simple terms: The activated receptor can both turn genes on or off and directly interact with other signaling proteins.
Corticosteroid receptors regulate gene expression by transactivation and transrepression, impacting cytokines, enzymes, and metabolic pathways. Non-genomic effects include rapid interactions with kinases and other signaling molecules, contributing to anti-inflammatory actions and side effects.
Physiological and Behavioral Outcomes
In simple terms: The combined molecular changes lead to effects on stress, immunity, metabolism, and even mood.
The response to corticosteroid manifests as altered immune cell function, reduced inflammation, changes in glucose and protein metabolism, electrolyte balance, and behavioral effects. These outcomes are clinically exploited in conditions such as asthma, COPD, and autoimmune diseases.
Key Genes Involved in GO:0031960 response to corticosteroid
The following genes are central to the response to corticosteroid pathway, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NR3C1 | Glucocorticoid receptor; mediates transcriptional effects of glucocorticoids | Polymorphisms affect asthma and COPD corticosteroid response |
| NR3C2 | Mineralocorticoid receptor; mediates aldosterone effects on electrolyte balance | Implicated in hypertension and metabolic syndrome |
| HSD11B1 | Converts inactive cortisone to active cortisol | Modulates local glucocorticoid availability |
| HSD11B2 | Inactivates cortisol to cortisone | Protects mineralocorticoid receptor from glucocorticoids |
| FKBP5 | Co-chaperone regulating glucocorticoid receptor sensitivity | Associated with psychiatric adverse effects and stress response |
| CRH | Corticotropin-releasing hormone; upstream regulator of cortisol production | Linked to stress response and mood disorders |
| POMC | Precursor of ACTH and beta-endorphin; regulated by corticosteroids | Feedback regulation of HPA axis |
| IL6 | Pro-inflammatory cytokine suppressed by corticosteroids | Marker of corticosteroid response in inflammatory diseases |
| TNF | Pro-inflammatory cytokine inhibited by corticosteroids | Target in autoimmune and inflammatory conditions |
| NFKB1 | Transcription factor repressed by glucocorticoid receptor | Central to anti-inflammatory effects |
| MAPK1 | Kinase modulated by non-genomic corticosteroid signaling | Involved in rapid corticosteroid effects |
| STAT3 | Transcription factor cross-talk with glucocorticoid receptor | Modulates inflammatory gene expression |
| CYP3A4 | Drug-metabolizing enzyme induced by corticosteroids | Affects drug interactions and clearance |
| GILZ | Glucocorticoid-induced leucine zipper; mediates anti-inflammatory effects | Biomarker of corticosteroid sensitivity |
| ANXA1 | Annexin A1; mediates anti-inflammatory actions of glucocorticoids | Therapeutic target in inflammation |
| DUSP1 | Dual-specificity phosphatase 1; inhibits MAPK pathways | Contributes to anti-inflammatory effects |
| SERPINE1 | Plasminogen activator inhibitor-1; regulated by corticosteroids | Linked to fibrosis and thrombosis |
How Is response to corticosteroid Regulated?
The response to corticosteroid is tightly regulated at multiple levels. The hypothalamic-pituitary-adrenal (HPA) axis controls endogenous corticosteroid production via CRH and ACTH, with negative feedback by cortisol. At the cellular level, receptor sensitivity is modulated by FKBP5 and other co-chaperones. Local ligand availability is controlled by HSD11B1 and HSD11B2. Additionally, inflammatory cytokines and kinases can alter glucocorticoid receptor function, contributing to corticosteroid resistance in diseases such as COPD and asthma.
response to corticosteroid and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NR3C1 | Asthma, COPD, psychiatric disorders | Knockout and point-mutation cell models to assess ligand sensitivity |
| FKBP5 | Mania, depression, stress-related disorders | Overexpression and knockout models to study receptor sensitivity |
| HSD11B1 | Metabolic syndrome, inflammation | Knock-in models to modulate local cortisol availability |
| IL6 | Immune thrombocytopenic purpura, inflammation | Knockout models to evaluate corticosteroid-mediated suppression |
| TNF | Autoimmune diseases, cryptogenic organizing pneumonia | Overexpression models to test corticosteroid resistance |
Corticosteroid Response in Immune Thrombocytopenic Purpura
Immune thrombocytopenic purpura (ITP) is an autoimmune bleeding disorder often treated with corticosteroids. Biomarkers for predicting response to corticosteroid therapy have been investigated, highlighting the clinical importance of GO:0031960. Genetic and immunological factors influence whether patients achieve remission, and understanding these mechanisms can guide treatment selection.
Asthma and COPD: Inhaled Corticosteroid Response
In children with asthma, genetic factors significantly affect inhaled corticosteroid response, with polymorphisms in genes such as NR3C1 and FKBP5 implicated. In COPD, machine learning models using clinical and genetic data can predict response to inhaled corticosteroid maintenance therapy, underscoring the multifactorial nature of corticosteroid response.
Psychiatric Adverse Effects of Corticosteroids
Corticosteroids can cause psychiatric adverse effects including mania, depression, and psychosis. A systematic review found that mania is a significant concern, particularly with high-dose or long-term use. These effects are thought to involve glucocorticoid receptor signaling in the brain and HPA axis dysregulation.
Corticosteroid-Responsive Lung Diseases
Cryptogenic organizing pneumonia often responds favorably to corticosteroids, but relapses can occur. Hard metal lung disease has also been reported to show favorable response to corticosteroid treatment. These conditions illustrate the therapeutic utility of corticosteroids and the need to understand response variability.
From response to corticosteroid-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NR3C1 mutation alter corticosteroid sensitivity? | Point-mutation knock-in cell line |
| What is the effect of FKBP5 overexpression on glucocorticoid receptor activity? | Overexpression cell model |
| Is HSD11B1 required for local cortisol activation? | Knockout cell model |
| How does a disease-associated SNP in NR3C1 affect transcriptional response? | Knock-in of SNP using CRISPR |
| Can CRISPR library screening identify novel regulators of corticosteroid response? | Genome-wide CRISPR knockout library |
| Does tagging of NR3C1 affect its localization? | Tagged knock-in with fluorescent protein |
How to Study the response to corticosteroid Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify corticosteroid-responsive genes |
| Proteomics | Protein abundance and modifications | Discover non-genomic effects and biomarkers |
| CRISPR knockout library screening | Gene essentiality and modifier effects | Identify novel regulators of corticosteroid response |
| ChIP-seq | Receptor binding sites on DNA | Map glucocorticoid response elements |
| Reporter assays | Transcriptional activity of GREs | Test genetic variants affecting response |
| Live-cell imaging | Receptor translocation and dynamics | Study real-time corticosteroid signaling |
| Machine learning | Predictive modeling of response | Forecast clinical corticosteroid response |
Transcriptomic Profiling by RNA-seq
RNA sequencing can quantify global gene expression changes following corticosteroid treatment, revealing transcriptional networks and identifying responsive genes. This method is useful for comparing wild-type and CRISPR-edited cells to dissect gene function.
Proteomic and Phosphoproteomic Analysis
Mass spectrometry-based proteomics can measure protein abundance and post-translational modifications after corticosteroid stimulation, uncovering non-genomic effects and feedback loops.
CRISPR Library Screening
Genome-wide CRISPR knockout or activation screens can identify genes that modulate corticosteroid response, such as those affecting cell viability or reporter activity. Hits can be validated in secondary assays.
Imaging and Reporter Assays
Fluorescently tagged glucocorticoid receptor and reporter constructs enable live-cell imaging of nuclear translocation and transcriptional activity. These assays provide spatial and temporal resolution of corticosteroid response.
How CRISPR Can Be Used to Study GO:0031960 response to corticosteroid
Knockout
CRISPR knockout of candidate genes such as NR3C1, FKBP5, or HSD11B1 can reveal their requirement for corticosteroid response. For example, knocking out NR3C1 abolishes glucocorticoid-mediated transcriptional changes, confirming its central role.
Point Mutation
Introducing specific point mutations (e.g., SNPs associated with asthma or COPD) into NR3C1 or FKBP5 allows functional assessment of their impact on ligand binding, transactivation, and clinical response.
Knock-in
Knock-in of reporter tags or disease-associated variants enables precise tracking of receptor localization and activity. For instance, tagging endogenous NR3C1 with a fluorescent protein allows live-cell imaging of nuclear translocation.
Overexpression
Overexpression of genes such as FKBP5 or GILZ can mimic gain-of-function states and test their ability to modulate corticosteroid sensitivity. This is useful for studying resistance mechanisms in asthma and COPD.
How EDITGENE Supports response to corticosteroid Research
Researchers studying response to corticosteroid-related genes often need to determine whether a candidate gene is causally involved in ligand sensitivity, transcriptional output, or clinical response. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for response to corticosteroid research.
Frequently Asked Questions About response to corticosteroid
What is GO:0031960 response to corticosteroid?
GO:0031960 is a Gene Ontology biological process term describing any process that results in a change in state or activity of a cell or organism as a result of a corticosteroid hormone stimulus, including glucocorticoids and mineralocorticoids.
What genes are involved in response to corticosteroid?
Key genes include NR3C1, NR3C2, HSD11B1, HSD11B2, FKBP5, CRH, POMC, IL6, TNF, and NFKB1, among others.
How does corticosteroid response affect asthma treatment?
Genetic factors influence inhaled corticosteroid response in children with asthma, with polymorphisms in NR3C1 and FKBP5 affecting efficacy.
Can corticosteroids cause psychiatric side effects?
Yes, corticosteroids can cause psychiatric adverse effects including mania, depression, and psychosis, particularly with high-dose or long-term use.
What is the role of NR3C1 in corticosteroid response?
NR3C1 encodes the glucocorticoid receptor, which mediates transcriptional and non-transcriptional effects of glucocorticoids.
How can CRISPR be used to study corticosteroid response?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of genes in the response to corticosteroid pathway.
What diseases are linked to corticosteroid response?
Diseases include immune thrombocytopenic purpura, asthma, COPD, cryptogenic organizing pneumonia, hard metal lung disease, and psychiatric disorders.
What is the difference between glucocorticoids and mineralocorticoids?
Glucocorticoids primarily regulate metabolism and inflammation, while mineralocorticoids regulate electrolyte and water balance; both are corticosteroids.
How is corticosteroid response regulated?
It is regulated by the HPA axis, local enzymes HSD11B1/HSD11B2, co-chaperones like FKBP5, and cross-talk with inflammatory signaling.
What research methods are used to study response to corticosteroid?
Methods include RNA-seq, proteomics, CRISPR screening, ChIP-seq, reporter assays, live-cell imaging, and machine learning.
Conclusion
GO:0031960 response to corticosteroid is a fundamental biological process with broad implications for physiology and disease. Understanding the genes and mechanisms involved can improve personalized use of corticosteroids in asthma, COPD, autoimmune diseases, and beyond. CRISPR-based models and bioinformatics tools are powerful approaches to dissect this pathway and identify novel therapeutic targets.
References
- 1. Nakamura N et al.. 2023. Biomarkers for predicting response to corticosteroid therapy for immune thrombocytopenic purpura.. Br J Haematol 201(4):774-782 PMID: 36708274
- 2. Duong-Thi-Ly H et al.. 2017. Effects of genetic factors to inhaled corticosteroid response in children with asthma: a literature review.. J Int Med Res 45(6):1818-1830 PMID: 29251255
- 3. Warrington TP et al.. 2006. Psychiatric adverse effects of corticosteroids.. Mayo Clin Proc 81(10):1361-7 PMID: 17036562
- 4. De Bock M et al.. 2024. Corticosteroids and mania: A systematic review.. World J Biol Psychiatry 25(3):161-174 PMID: 38363330
- 5. Rice JB et al.. 2017. Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review.. Clin Ther 39(11):2216-2229 PMID: 29055500
- 6. Wu SC et al.. 2025. Predicting response to inhaled corticosteroid maintenance therapy in patients with chronic obstructive pulmonary disease using machine learning models.. Respir Med 248:108378 PMID: 41015395
- 7. Root MZ et al.. 2026. Cryptogenic Organizing Pneumonia.. Semin Respir Crit Care Med 47(4):343-349 PMID: 40967604
- 8. Chiba Y et al.. 2019. Hard Metal Lung Disease with Favorable Response to Corticosteroid Treatment: A Case Report and Literature Review.. Tohoku J Exp Med 247(1):51-58 PMID: 30674737
